[{"AccountsPayableCurrent_0_Q2_USD":10647000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":13746000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":123000.0,"OtherAssetsNoncurrent_0_Q2_USD":4607000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":0.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":0.0,"OtherLiabilitiesCurrent_0_Q2_USD":129000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":288000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-77000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":259000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":447000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockSharesAuthorized_0_Q2_shares":25000000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":0.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":12543000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":6043000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2173000.0,"OperatingExpenses_2_Q2_USD":75460000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":2080000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q2_USD":0.0,"LongTermDebtNoncurrent_0_Q2_USD":5027000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":34388000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-447000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-61490000.0,"NetIncomeLoss_1_Q2_USD":-40913000.0,"NetIncomeLoss_2_Q2_USD":-75606000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":-75606000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-40913000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":-40913000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":-75606000.0,"NonoperatingIncomeExpense_1_Q2_USD":-86000.0,"NonoperatingIncomeExpense_2_Q2_USD":-167000.0,"OperatingExpenses_1_Q2_USD":40838000.0,"OperatingLeaseLiability_0_Q2_USD":14716000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":417000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":0.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":966000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":3548386.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":6.07,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_Q2_shares":270082.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":2325657.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":13.45,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":7977545.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":11.19,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":5.06,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":9.35,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":19.27,"StockholdersEquity_0_Q2_USD":195513000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":190978.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":202000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":69303899.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":69616467.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.008,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q2_pure":0.01,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.83,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q2_pure":0.83,"ProfitLoss_2_Q2_USD":-75606000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0_Q2_USD":1901000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":31955000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":59370000.0,"RestrictedCashNoncurrent_0_Q2_USD":478000.0,"RetainageDeposit_0_Q2_USD":4129000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-356025000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":1907000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":11000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1_Q2_USD":0.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2_Q2_USD":213000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":3783000.0,"SecurityDeposit_0_Q2_USD":478000.0,"ShareBasedCompensation_2_Q2_USD":8621000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q2_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":21000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q2_USD":1213000.0,"LongTermDebtCurrent_0_Q2_USD":173000.0,"LongTermDebt_0_Q2_USD":4870000.0,"CommonStockSharesIssued_0_Q2_shares":71401216.0,"CommonStockSharesOutstanding_0_Q2_shares":71401216.0,"CommonStockValue_0_Q2_USD":7000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-40913000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-75606000.0,"ContractWithCustomerAssetNet_0_Q2_USD":0.0,"ContractWithCustomerLiability_0_Q2_USD":3966000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":3966000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":11000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":21000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q2_USD":0.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_2_Q2_USD":0.0,"DebtInstrumentCarryingAmount_0_Q2_USD":5200000.0,"DebtInstrumentUnamortizedPremium_0_Q2_USD":57000.0,"DeferredFinanceCostsNet_0_Q2_USD":214000.0,"CommonStockSharesAuthorized_0_Q2_shares":175000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":9087330.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":0.0,"AccruedLiabilitiesCurrent_0_Q2_USD":23383000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":551531000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_1_Q2_USD":417000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4582000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":4582000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":8621000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":432000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":9087330.0,"Assets_0_Q2_USD":253685000.0,"AssetsCurrent_0_Q2_USD":233431000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":46000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":227388000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":227866000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-27549000.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q2_shares":39474.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":9087330.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":69616467.0,"EarningsPerShareBasic_2_Q2_USD":-1.09,"EarningsPerShareDiluted_2_Q2_USD":-1.09,"InterestExpense_2_Q2_USD":188000.0,"InterestExpenseDebt_1_Q2_USD":89000.0,"InterestExpenseDebt_2_Q2_USD":177000.0,"InterestPaidNet_2_Q2_USD":122000.0,"InvestmentIncomeInterest_1_Q2_USD":9000.0,"InvestmentIncomeInterest_2_Q2_USD":21000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":19103000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":3795000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":4027000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":3909000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1915000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":4387000.0,"Liabilities_0_Q2_USD":58172000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":253685000.0,"LiabilitiesCurrent_0_Q2_USD":40471000.0,"InterestExpense_1_Q2_USD":95000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2418000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":2296000.0,"IncreaseDecreaseInOperatingLeaseLiability_1_Q2_USD":3783000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.59,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":4555000.0,"FinanceLeaseLiability_0_Q2_USD":417000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q2_USD":447000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":128000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":60000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":121000.0,"EarningsPerShareBasic_1_Q2_USD":-0.59,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":82000.0,"FinanceLeasePrincipalPayments_2_Q2_USD":74000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":8883000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":16090000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":2270000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":7139000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-21000.0,"IncreaseDecreaseInOperatingLeaseLiability_2_Q2_USD":-660000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":30000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":69303899.0,"Ticker":"MRSN","CIK":"1442836","name":"MERSANA THERAPEUTICS, INC.","OfficialName":"Mersana Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"345233797.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210806"}]